RNF128 and colorectal carcinoma: Based on experimental data and the cancer genome profiling data, it is reasonable to infer that RNF128 acts as a promoter, not a suppressor, during CRC progression and that RNF128 knockdown inhibits the proliferation, migration and invasion of CRC cells.